243 related articles for article (PubMed ID: 24416158)
1. Global gene expression analysis of canine osteosarcoma stem cells reveals a novel role for COX-2 in tumour initiation.
Pang LY; Gatenby EL; Kamida A; Whitelaw BA; Hupp TR; Argyle DJ
PLoS One; 2014; 9(1):e83144. PubMed ID: 24416158
[TBL] [Abstract][Full Text] [Related]
2. Enhanced expression of cyclooxygenase-2 related multi-drug resistance gene in melanoma and osteosarcoma cell lines by TSG-6 secreted from canine adipose-derived mesenchymal stem/stromal cells.
Yang SJ; An JH; Park SM; Lee JH; Chae HK; Lee KM; Song WJ; Youn HY
Vet Med Sci; 2021 May; 7(3):968-978. PubMed ID: 33570264
[TBL] [Abstract][Full Text] [Related]
3. In vitro and in vivo characterization of stem-like cells from canine osteosarcoma and assessment of drug sensitivity.
Gatti M; Solari A; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Würth R; Corsaro A; Bajetto A; Ratto A; Ferrari A; Daga A; Barbieri F; Florio T
Exp Cell Res; 2018 Feb; 363(1):48-64. PubMed ID: 29305964
[TBL] [Abstract][Full Text] [Related]
4. Antineoplastic effect of the cyclooxygenase inhibitor meloxicam on canine osteosarcoma cells.
Wolfesberger B; Walter I; Hoelzl C; Thalhammer JG; Egerbacher M
Res Vet Sci; 2006 Jun; 80(3):308-16. PubMed ID: 16182328
[TBL] [Abstract][Full Text] [Related]
5. HES1, a target of Notch signaling, is elevated in canine osteosarcoma, but reduced in the most aggressive tumors.
Dailey DD; Anfinsen KP; Pfaff LE; Ehrhart EJ; Charles JB; Bønsdorff TB; Thamm DH; Powers BE; Jonasdottir TJ; Duval DL
BMC Vet Res; 2013 Jul; 9():130. PubMed ID: 23816051
[TBL] [Abstract][Full Text] [Related]
6. HDAC2 depletion promotes osteosarcoma's stemness both in vitro and in vivo: a study on a putative new target for CSCs directed therapy.
La Noce M; Paino F; Mele L; Papaccio G; Regad T; Lombardi A; Papaccio F; Desiderio V; Tirino V
J Exp Clin Cancer Res; 2018 Dec; 37(1):296. PubMed ID: 30509303
[TBL] [Abstract][Full Text] [Related]
7. Visualizing the cancer stem-like properties of canine tumour cells with low proteasome activity.
Sung K; Hosoya K; Murase Y; Deguchi T; Kim S; Sunaga T; Okumura M
Vet Comp Oncol; 2022 Mar; 20(1):324-335. PubMed ID: 34719098
[TBL] [Abstract][Full Text] [Related]
8. Cancer stem cells in osteosarcoma.
Brown HK; Tellez-Gabriel M; Heymann D
Cancer Lett; 2017 Feb; 386():189-195. PubMed ID: 27894960
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical expression of COX-2, mPGES and EP2 receptor in normal and reactive canine bone and in canine osteosarcoma.
Millanta F; Asproni P; Cancedda S; Vignoli M; Bacci B; Poli A
J Comp Pathol; 2012; 147(2-3):153-60. PubMed ID: 22633646
[TBL] [Abstract][Full Text] [Related]
10. Isolation and characterisation of cancer stem cells from canine osteosarcoma.
Wilson H; Huelsmeyer M; Chun R; Young KM; Friedrichs K; Argyle DJ
Vet J; 2008 Jan; 175(1):69-75. PubMed ID: 17851099
[TBL] [Abstract][Full Text] [Related]
11. Comparative biology of human and canine osteosarcoma.
Mueller F; Fuchs B; Kaser-Hotz B
Anticancer Res; 2007; 27(1A):155-64. PubMed ID: 17352227
[TBL] [Abstract][Full Text] [Related]
12. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic implications of an enriched cancer stem-like cell population in a human osteosarcoma cell line.
Martins-Neves SR; Lopes ÁO; do Carmo A; Paiva AA; Simões PC; Abrunhosa AJ; Gomes CM
BMC Cancer; 2012 Apr; 12():139. PubMed ID: 22475227
[TBL] [Abstract][Full Text] [Related]
14. Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity.
Yi XJ; Zhao YH; Qiao LX; Jin CL; Tian J; Li QS
Mol Med Rep; 2015 Oct; 12(4):5042-8. PubMed ID: 26134785
[TBL] [Abstract][Full Text] [Related]
15. Canine osteosarcoma cell lines contain stem-like cancer cells: biological and pharmacological characterization.
Gatti M; Wurth R; Vito G; Pattarozzi A; Campanella C; Thellung S; Maniscalco L; De Maria R; Villa V; Corsaro A; Nizzari M; Bajetto A; Ratto A; Ferrari A; Barbieri F; Florio T
Jpn J Vet Res; 2016 May; 64(2):101-12. PubMed ID: 27506084
[TBL] [Abstract][Full Text] [Related]
16. Canine osteosarcoma: a naturally occurring disease to inform pediatric oncology.
Fenger JM; London CA; Kisseberth WC
ILAR J; 2014; 55(1):69-85. PubMed ID: 24936031
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 promotes cell proliferation, migration and invasion in U2OS human osteosarcoma cells.
Lee EJ; Choi EM; Kim SR; Park JH; Kim H; Ha KS; Kim YM; Kim SS; Choe M; Kim JI; Han JA
Exp Mol Med; 2007 Aug; 39(4):469-76. PubMed ID: 17934334
[TBL] [Abstract][Full Text] [Related]
18. Radioresistance of cancer stem-like cell derived from canine tumours.
Tanabe A; Deguchi T; Sato T; Nemoto Y; Maruo T; Madarame H; Shida T; Naya Y; Ogihara K; Sahara H
Vet Comp Oncol; 2016 Sep; 14(3):e93-e101. PubMed ID: 25070729
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of P16 expression in canine appendicular osteosarcoma.
Murphy BG; Mok MY; York D; Rebhun R; Woolard KD; Hillman C; Dickinson P; Skorupski K
BMC Vet Res; 2017 Jun; 13(1):189. PubMed ID: 28633676
[TBL] [Abstract][Full Text] [Related]
20. Enrofloxacin enhances the effects of chemotherapy in canine osteosarcoma cells with mutant and wild-type p53.
York D; Withers SS; Watson KD; Seo KW; Rebhun RB
Vet Comp Oncol; 2017 Sep; 15(3):1087-1100. PubMed ID: 27333821
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]